Impact of single tablet regimens on adherence and prescription errors? How big an issue and how relevant in both clinical and economic terms (iSTRAP)

First published 19/12/2013

Last updated 23/04/2024

EU PAS number:

EUPAS5440

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

iSTRAP GS-EU-264-1271_final_16May14

English (796.14 KB - PDF) View document

Study results

CSR SUMMARY-pgs. 4-10_FINAL_GS-EU-264-1271_iSTRAP_20170224

English (246.17 KB - PDF) View document

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

Signed checklist for study protocols

ENCePPChecklistforStudyProtocols_27Nov14_signed

English (491.08 KB - PDF) View document

Impact of single tablet regimens on adherence and prescription errors? How big an issue and how relevant in both clinical and economic terms (iSTRAP)

Secondary tabs

Share this page